The Mesothelioma Center News – Page 23
-
news
Asbestos Exposure & BansThe 16th Annual International Asbestos Awareness and Prevention Conference takes place Sept. 17-18, featuring 40 speakers from seven countries plus the first-ever Art, Advocacy… -
news
Research & Clinical TrialsMesothelioma Research, COVID Findings Featured at IASLC Conference
Researchers from around the world presented their insights into serious lung health issues, including mesothelioma, during the International Association for the Study of… -
news
Research & Clinical TrialsRamucirumab Shows Survival Benefits with Pleural Mesothelioma
Adding the drug ramucirumab to gemcitabine chemotherapy worked especially well in a recent clinical trial involving second-line treatment for patients with… -
news
Asbestos Exposure & BansNew Report Details 9/11 Health Effects on FDNY Firefighters
A recent report from the Fire Department of New York World Trade Center Health Program outlines the 9/11-related health effects firefighters are dealing… -
news
Asbestos Exposure & BansNYC Mayor Waives Asbestos Fees in Response to Hurricane Ida
New York City Mayor Bill de Blasio has waived fees for asbestos removal as part of the recovery response to Hurricane Ida. The mayor… -
news
Treatment & DoctorsMesothelioma Treatment Program Expanding in Central Florida
When he first joined AdventHealth Orlando in 2019, thoracic surgeon Dr. Marcelo DaSilva wondered just how successful he could be in creating… -
news
Research & Clinical TrialsStudy: Pleural Mesothelioma Treatment Effective with Peritoneal Disease
The University of Texas MD Anderson Cancer Center has taken an immunotherapy treatment recently approved by the U.S. Food and Drug Administration… -
news
Research & Clinical TrialsResearchers Study New Immunotherapy Combination for Mesothelioma
The immunotherapy combination of tremelimumab and durvalumab has shown surprising efficacy, particularly as a second-line treatment option for patients with pleural… -
news
Research & Clinical TrialsMesothelioma Olaparib Clinical Trial Targets Genetic Mutation
The mesothelioma program at University of Chicago Medicine is recruiting patients for its latest clinical trial involving olaparib, an oral chemotherapy drug… -
news
Treatment & DoctorsSocial Security Adds Pericardial Mesothelioma to Disabilities List
The U.S. Social Security Administration has added pericardial mesothelioma to its Compassionate Allowances list, accelerating the disabilities application process for this very rare…